NATURE’S SUNSHINE PRODUCTS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Cash and Cash Equivalents, Period Increase (Decrease) of $7.73 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-08.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-03-08
- NATURE’S SUNSHINE PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $2.78M.
- NATURE’S SUNSHINE PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $961.00K, a 93.94% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $4.59M.
- NATURE’S SUNSHINE PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$607.00K, a 178.22% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $7.73M, a 27.27% decline from fiscal 2017.
- NATURE’S SUNSHINE PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $10.63M.
- NATURE’S SUNSHINE PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$9.14M.
- NATURE’S SUNSHINE PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$17.28M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $3.74M derived: sum of 2 quarters · filed 2019-03-08 | $8.34M derived: sum of 3 quarters · filed 2019-03-08 | $7.73M 10-K · filed 2019-03-08 |
| 2018-09-30 | $961.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $5.56M derived: sum of 2 quarters · filed 2018-11-08 | $4.95M 10-Q · filed 2018-11-08 | $167.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2018-06-30 | $4.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $3.99M 10-Q · filed 2018-08-08 | -$794.00K derived: sum of 3 quarters · filed 2019-03-08 | $15.08M derived: sum of 4 quarters · filed 2019-03-08 |
| 2018-03-31 | -$607.00K 10-Q · filed 2018-05-10 | -$5.39M derived: sum of 2 quarters · filed 2019-03-08 | $10.48M derived: sum of 3 quarters · filed 2019-03-08 | $9.24M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-12-31 | -$4.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $11.09M derived: sum of 2 quarters · filed 2019-03-08 | $9.85M derived: sum of 3 quarters · filed 2019-03-08 | $10.63M 10-K · filed 2019-03-08 |
| 2017-09-30 | $15.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $14.63M derived: sum of 2 quarters · filed 2018-11-08 | $15.41M 10-Q · filed 2018-11-08 | $7.25M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | -$1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$463.00K 10-Q · filed 2018-08-08 | -$8.62M derived: sum of 3 quarters · filed 2019-03-08 | -$9.61M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $776.00K 10-Q · filed 2018-05-10 | -$7.38M derived: sum of 2 quarters · filed 2019-03-08 | -$8.37M derived: sum of 3 quarters · filed 2019-03-08 | -$13.37M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | -$8.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$9.14M derived: sum of 2 quarters · filed 2019-03-08 | -$14.15M derived: sum of 3 quarters · filed 2019-03-08 | -$9.14M 10-K · filed 2019-03-08 |
| 2016-09-30 | -$985.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$5.99M derived: sum of 2 quarters · filed 2017-11-09 | -$977.00K 10-Q · filed 2017-11-09 | -$3.44M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $8.00K 10-Q · filed 2017-08-09 | -$2.45M derived: sum of 3 quarters · filed 2018-03-16 | -$4.79M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $5.01M 10-Q · filed 2017-05-10 | $2.55M derived: sum of 2 quarters · filed 2018-03-16 | $216.00K derived: sum of 3 quarters · filed 2018-03-16 | -$3.63M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$4.80M derived: sum of 2 quarters · filed 2018-03-16 | -$8.64M derived: sum of 3 quarters · filed 2018-03-16 | -$17.28M 10-K · filed 2018-03-16 |
| 2015-09-30 | -$2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$6.18M derived: sum of 2 quarters · filed 2016-11-09 | -$14.82M 10-Q · filed 2016-11-09 | -$26.57M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$12.48M 10-Q · filed 2016-08-09 | -$24.24M derived: sum of 3 quarters · filed 2017-03-14 | -$22.34M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | -$8.63M 10-Q · filed 2016-05-10 | -$20.39M derived: sum of 2 quarters · filed 2017-03-14 | -$18.49M derived: sum of 3 quarters · filed 2017-03-14 | -$21.40M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | -$11.76M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$9.86M derived: sum of 2 quarters · filed 2017-03-14 | -$12.77M derived: sum of 3 quarters · filed 2017-03-14 | -$18.55M 10-K · filed 2017-03-14 |
| 2014-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$1.01M derived: sum of 2 quarters · filed 2015-11-06 | -$6.79M 10-Q · filed 2015-11-06 | |
| 2014-06-30 | -$2.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$8.69M 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | -$5.78M 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | -$1.99M 10-K · filed 2016-03-14 | |||
| 2012-12-31 | $20.27M 10-K · filed 2015-03-13 | |||
| 2011-12-31 | $4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$4.03M derived: sum of 2 quarters · filed 2013-03-07 | $11.37M 10-K · filed 2013-03-07 | |
| 2011-09-30 | -$8.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $6.50M 10-Q · filed 2011-11-08 | ||
| 2011-06-30 | $15.39M 10-Q · filed 2011-08-05 | |||
| 2010-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $7.59M derived: sum of 2 quarters · filed 2013-03-07 | $12.07M 10-K · filed 2013-03-07 | |
| 2010-09-30 | $5.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $10.12M 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $4.47M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $685.00K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |